相似文献
1
MMR vaccination: new thought.
Indian Pediatr. 2006 Jun;43(6):555-6.
2
An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
J Infect Dis. 2004 May 1;189 Suppl 1:S131-45. doi: 10.1086/378987.
3
The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
Br J Gen Pract. 2000 Dec;50(461):969-71.
4
Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
Bone Marrow Transplant. 2004 Jun;33(12):1187-90. doi: 10.1038/sj.bmt.1704476.
5
Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
Commun Dis Intell. 1998 Aug 6;22(8):159.
6
Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
J Infect Dis. 2004 May 1;189 Suppl 1:S116-22. doi: 10.1086/378691.
7
Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
East Mediterr Health J. 2009 Jan-Feb;15(1):85-93.
8
Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Scand J Immunol. 2006 Dec;64(6):684-9. doi: 10.1111/j.1365-3083.2006.01857.x.
9
[Measles, mumps, rubella: important health risks].
Rev Infirm. 2000 Oct(64):13-5.
10
MMR vaccination and disease elimination: the Finnish experience.
Expert Rev Vaccines. 2010 Sep;9(9):1045-53. doi: 10.1586/erv.10.99.
引用本文的文献
1
A Mixed Outbreak of Rubeola-Rubella in District Kangra of Northern India.
J Family Med Prim Care. 2013 Oct-Dec;2(4):354-9. doi: 10.4103/2249-4863.123904.
Zotero 插件